Apolipoprotein E in macrophages and hepatocytes is degraded via the proteasomal pathway

Biochemical and Biophysical Research Communications

Volumn 282, Issue 2, 2001, Pages 608-614

  Wenner, Claudia ^a   Lorkowski, Stefan ^a   Engel, Thomas ^a   Cullen, Paul ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Apolipoprotein E; Atherosclerosis; Hemagglutinin; HepG2 cell; Macrophage; Proteasome; Ubiquitin

Indexed keywords

APOLIPOPROTEIN E; EPITOPE; LACTACYSTIN; PROTEASOME; UBIQUITIN; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL STRAIN HEPG2; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; INFLUENZA VIRUS; LIVER CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; WESTERN BLOTTING;

INFLUENZA VIRUS;

EID: 0034815763     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4611     Document Type: Article

References (29)

1. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
2. Apolipoprotein E secretion by macrophages: Its potential physiological functions
3. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice
4. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages
5. Transcriptional and posttranscriptional control of apolipoprotein E gene expression in differentiating human monocytes
6. Cell surface proteoglycans modulate net synthesis and secretion of macrophage apolipoprotein E
7. Lysosomal degradation and sorting of apolipoprotein E in macrophages
8. Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway
9. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B
10. Degradation of macrophage apoE in a nonlysosomal compartment
11. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
12. Lactacystin, proteasome function, and cell fate
13. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin
14. The ubiquitin system and the N-end rule pathway
15. Ubiquitin-dependent protein degradation
16. The ubiquitin system
17. The ubiquitin system
18. The ubiquitin conjugation system
19. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways
20. Retrograde protein translocation: ERADication of secretory proteins in health and disease
21. Intracellular degradation of newly synthesized apolipoprotein B
22. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70
23. Regulated cotranslational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein
24. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum
25. Ubiquitin-proteasome-dependent degradation of apolipoprotein B100 in vitro
26. Translocation-arrested apolipoprotein B evades proteasome degradation via a sterol-sensitive block in ubiquitin conjugation
27. The amino-terminal domain of apolipoprotein B does not undergo retrograde translocation from the endoplasmic reticulum to the cytosol: Proteasomal degradation of nascent apolipoprotein B begins at the carboxyl-terminus of the protein while apolipoprotein B is still in its original translocon
28. Apolipoprotein A-I stimulates secretion of apolipoprotein E by foam cell macrophages
29. Sterols and inhibitors of sterol transport modulate the degradation and secretion of macrophage apoE: Requirement for the C-terminal domain